Heron Therapeutics's total assets for Q3 2025 were $248.95M, an increase of 7.26% from the previous quarter. HRTX total liabilities were $234.06M for the fiscal quarter, a -9.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.